HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained HIV negative. Daniel O’Day, Gilead’s chairman and chief executive officer, called…

Read More
Rubio foreign aid freeze leads to USAID staff suspensions and contractor terminations

Rubio foreign aid freeze leads to USAID staff suspensions and contractor terminations

Dozens of senior staff inside the U.S. Agency for International Development, USAID, have been placed on administrative leave until further notice, and hundreds of contractors have had their employment furloughed or terminated, multiple sources told CBS News. This followed Secretary of State Marco Rubio’s order last Friday that placed an immediate halt on virtually all…

Read More